Results 81 to 90 of about 5,627 (198)

Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity

open access: yes, 2018
Significance Recombinant immunotoxins are anticancer agents consisting of Fv of an antibody that targets a cancer cell and a protein toxin that kills the cell.
Ira Pastan   +7 more
core   +1 more source

T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications

open access: yesAntibodies, 2013
Major histocompatibility complex (MHC) class I molecules are key in the immune response against malignant cells by shaping the T-cell repertoire and presenting peptides from endogenous antigens to CD8+ cytotoxic T cells.
Maya Cohen, Yoram Reiter
doaj   +1 more source

Evaluation of immunotoxins containing single-chain ribosome inactivating proteins and an anti-CD22 monoclonal antibody (OM 124): in vitro an in vivo studies

open access: yes, 1998
Immunotoxins were prepared with three ribosome-inactivating proteins (RIP), momordin, pokeweed antiviral protein from seeds (PAP-S) and saporin- S6, linked to the anti-CD22 monoclonal antibody OM124. These immunotoxins inhibited protein synthesis by CD22-
TERENZI A   +16 more
core   +1 more source

Use of Anti-HIV Immunotoxins as Probes of the Biology of HIV-Infected Cells [PDF]

open access: yes, 1994
OBJECTIVE: Anti-human immunodeficiency virus (HIV) immunotoxins are potential treatments for HIV infection. but they may also be used as probes to study the relationship between HIV and the cell it infects.
Hua Fang, SETH H Pincus, Jan McClure
core   +1 more source

Ricin: An Ancient Story for a Timeless Plant Toxin

open access: yesToxins, 2019
The castor plant (Ricinus communis L.) has been known since time immemorial in traditional medicine in the pharmacopeia of Mediterranean and eastern ancient cultures. Moreover, it is still used in folk medicine worldwide.
Letizia Polito   +4 more
doaj   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells

open access: yes, 1989
B cell-restricted immunotoxins were constructed by conjugating anti-B monoclonal antibodies to saporin, the major ribosome inactivating protein from the seeds of the plant Saponaria officinalis.
S. Siena   +8 more
core   +1 more source

Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy

open access: yesPharmaceuticals
The present review provides a detailed and comprehensive discussion on antibody–drug conjugates (ADCs) as an evolving new modality in the current therapeutic landscape of malignant diseases.
Rositsa Mihaylova   +3 more
doaj   +1 more source

Supplementary Figure 1 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity

open access: yes, 2012
PDF file - 4112KB, Competitive internalization assay of 20nM immunotoxins with different concentration of the Her2/neu ECD on BT474 M1 cells.
James D. Marks (82191)   +12 more
core   +1 more source

Generation of active immunotoxins containing recombinant restrictocin

open access: yes, 1996
Restrictocin, a toxin produced by the fungusAspergillus restrictus,is a potent inhibitor of eukaryotic protein synthesis. Recombinant restrictocin was made inEscherichia coliand purified to homogeneity in large amounts.
Rathore, Dharmendar, Batra, Janendra K.
core   +1 more source

Home - About - Disclaimer - Privacy